An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma.

Journal: Cell

Published: 2019-10-03

DOI: 10.1016/j.cell.2019.09.009

Affiliations: 20

Authors: 50

Go to article
Institutions Share
Genentech, Inc., United States of America (USA) 0.26
Department of Antibody Engineering, Genentech, Inc., United States of America (USA) 0.10
Department of Early Discovery Biochemistry, Genentech, Inc., United States of America (USA) 0.08
Department of Translational Immunology, Genentech, Inc., United States of America (USA) 0.08
Department of Structural Biology, Genentech, Inc., United States of America (USA) 0.08
UCSF Department of Medicine (DOM), United States of America (USA) 0.07
Department of Biochemical and Cellular Pharmacology, Genentech, Inc., United States of America (USA) 0.06
Department of Bioinformatics and Computational Biology, Genentech, Inc., United States of America (USA) 0.04
Department of Protein Analytical Chemistry, Genentech, Inc., United States of America (USA) 0.04
Department of Drug Metabolism and Pharmacokinetics (DMPK), Genentech, Inc., United States of America (USA) 0.04
Department of Safety Assessment, Genentech, Inc., United States of America (USA) 0.04
San Francisco VA Medical Center (SFVAMC), United States of America (USA) 0.03
Department of BioMolecular Resources, Genentech, Inc., United States of America (USA) 0.02
VCU Department of Internal Medicine, United States of America (USA) 0.02
Charité Department of Dermatology, Venerology and Allergology, Germany 0.02
Department of Pathology, Genentech, Inc., United States of America (USA) 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER